[go: up one dir, main page]

FR2034543A1 - L-tyrosine contg compsn in glucose for - treating fatigue syndrome - Google Patents

L-tyrosine contg compsn in glucose for - treating fatigue syndrome

Info

Publication number
FR2034543A1
FR2034543A1 FR7002075A FR7002075A FR2034543A1 FR 2034543 A1 FR2034543 A1 FR 2034543A1 FR 7002075 A FR7002075 A FR 7002075A FR 7002075 A FR7002075 A FR 7002075A FR 2034543 A1 FR2034543 A1 FR 2034543A1
Authority
FR
France
Prior art keywords
contg
glucose
tyrosine
compsn
fatigue syndrome
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7002075A
Other languages
French (fr)
Other versions
FR2034543B1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ETD EXPERIMENTALES CENTRE
Original Assignee
ETD EXPERIMENTALES CENTRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ETD EXPERIMENTALES CENTRE filed Critical ETD EXPERIMENTALES CENTRE
Publication of FR2034543A1 publication Critical patent/FR2034543A1/en
Application granted granted Critical
Publication of FR2034543B1 publication Critical patent/FR2034543B1/fr
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Novel comp. (I) contg. a major amt. of L-tyrosine used for treating aggression and fatigue syndromes and for medical and surgical reanimation. Pref. a soln. contg. 1 mg/ml. of (I) in 5-10% glucose for dripwise intravenous administration.
FR7002075A 1969-02-13 1970-01-21 L-tyrosine contg compsn in glucose for - treating fatigue syndrome Granted FR2034543A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB786669 1969-02-13

Publications (2)

Publication Number Publication Date
FR2034543A1 true FR2034543A1 (en) 1970-12-11
FR2034543B1 FR2034543B1 (en) 1973-01-12

Family

ID=9841291

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7002075A Granted FR2034543A1 (en) 1969-02-13 1970-01-21 L-tyrosine contg compsn in glucose for - treating fatigue syndrome

Country Status (1)

Country Link
FR (1) FR2034543A1 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1983000285A1 (en) * 1981-07-15 1983-02-03 Wurtman, Richard, J. Process and composition for increasing blood pressure
EP0070048A3 (en) * 1978-10-19 1983-03-16 Laboratoires Serobiologiques S.A. Tyrosine derivatives and chemical process for the preparation of these tyrosine derivatives
EP0083993A1 (en) * 1982-01-11 1983-07-20 Massachusetts Institute Of Technology Compositions for use in increasing brain tyrosine levels

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0070048A3 (en) * 1978-10-19 1983-03-16 Laboratoires Serobiologiques S.A. Tyrosine derivatives and chemical process for the preparation of these tyrosine derivatives
WO1983000285A1 (en) * 1981-07-15 1983-02-03 Wurtman, Richard, J. Process and composition for increasing blood pressure
EP0083993A1 (en) * 1982-01-11 1983-07-20 Massachusetts Institute Of Technology Compositions for use in increasing brain tyrosine levels

Also Published As

Publication number Publication date
FR2034543B1 (en) 1973-01-12

Similar Documents

Publication Publication Date Title
Penttilå et al. Interaction between doxycycline and some antiepileptic drugs
PL287844A1 (en) Method of obtaining an oraly administered composite medicine for treating interstinal inflamatory diseases
HU9300636D0 (en) Medical preparatives, method for producing them and their applications as analgetic and/or febrifuge in human and veterinary medicine
FI940787A0 (en) Dosage form for short-term administration of the drug
EP1019072A4 (en) Method for assisting in differential diagnosis and treatment of autistic syndromes
ATE71843T1 (en) TREATMENT OF RESPIRATORY WELLBEING SYNDROME IN ADULTS.
ATE183923T1 (en) ENTERAL PREPARATIONS FOR CANCER THERAPY
KR910005858A (en) Fatty acid therapy
MX9205568A (en) PHARMACEUTICAL COMPOSITION CONTAINING AMOUNTS OF 5-AMINO-1BETA-D-RIBOFURANOSIL-IMIDAZOLE-4-CARBOXAMIDE.
IT1199972B (en) PHARMACEUTICAL COMPOSITIONS FOR THE THERAPY OF INVOLUTIVE CEREBRAL SYNDROMES AND MENTAL DECAY
Valanne et al. Effect of a small dose of droperidol on nausea, vomiting and recovery after outpatient enflurane anaesthesia
FR2034543A1 (en) L-tyrosine contg compsn in glucose for - treating fatigue syndrome
DK39685D0 (en) ENTERALLY APPLICABLE COMPOSITION AND PROCEDURE FOR ITS PREPARATION
KR950013513A (en) Moenomycin and its derivatives for the manufacture of a medicament, and a medicament containing moenomycin or its derivatives
Stanley et al. Streptozotocin treatment of malignant islet cell tumour
Ockelford et al. A double-blind placebo controlled trial to study the efficacy and safety of a low molecular weight heparin fragment (Fragmin) in patients having major elective general surgery
Lai et al. Burning-Feet Syndrome: Case Due to Malabsorption and Responding to Riboflavine
Whipple Jr The cure of a patient with a very resistant streptococcus viridans endocarditis with massive penicillin therapy (average daily dose of eighty-six million units)
RU97104198A (en) METHOD FOR TREATING RESPIRATORY DISTRESS SYNDROME
Jebson Intramuscular lignocaine 2% and 10%
FR2160293A1 (en) Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity
Salo et al. Tinidazole in the prophylaxis of post-appendicectomy infections
Balas et al. Venous Thrombosis in Childhood
NL7211647A (en) Stabilisation of sodium naphcillin solns - using citrate soln
FURUKAWA Effect of histamine on microcirculation and influence of diphenhydramine on that

Legal Events

Date Code Title Description
ST Notification of lapse